Novo Nordisk to Acquire Catalent for $16.5 Billion
Novo Nordisk, a leading pharmaceutical company, has recently announced its agreement to acquire Catalent for a staggering $16.5 billion in cash. This news has sent Catalent stock soaring by 9%…
Novo Nordisk, a leading pharmaceutical company, has recently announced its agreement to acquire Catalent for a staggering $16.5 billion in cash. This news has sent Catalent stock soaring by 9%…